News & Updates

Show Multimedia Only

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

04 Jan 2021 by

In a fully remote, preliminary study evaluating adult outpatients with mild COVID-19, the likelihood of clinical deterioration* over 15 days was lower among those treated with fluvoxamine – an SSRI** and a strong σ-1 receptor (S1R) agonist – compared with those receiving placebo.

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

04 Jan 2021

Dihydropyridine CCBs keep users from catching tuberculosis

02 Jan 2021 by

Dihydropyridine calcium channel blockers (CCBs), commonly used to manage hypertension, also help lower the risk of developing tuberculosis, as shown in a study.

Dihydropyridine CCBs keep users from catching tuberculosis

02 Jan 2021

SARS-CoV-2 does not transmit from mother to child during pregnancy

25 Dec 2020 by

A new study finds no evidence of vertical transmissions of SARS-CoV-2 from mother to child during pregnancy, but there appears to be limited transplacental transfer of anti-SARS-CoV-2 antibodies to the neonates in utero.

SARS-CoV-2 does not transmit from mother to child during pregnancy

25 Dec 2020

News & Updates

Showing Respirology articles

Showing

Specialty:

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

Dihydropyridine CCBs keep users from catching tuberculosis

Dihydropyridine CCBs keep users from catching tuberculosis

SARS-CoV-2 does not transmit from mother to child during pregnancy

SARS-CoV-2 does not transmit from mother to child during pregnancy